Walt Addison Linscott - 04 Aug 2021 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Chief Business Officer
Signature
/s/ Walt Linscott
Issuer symbol
INDP
Transactions as of
04 Aug 2021
Net transactions value
$0
Form type
4
Filing time
06 Aug 2021, 17:00:42 UTC
Previous filing
02 Aug 2021
Next filing
28 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Award $0 +210,000 $0.000000 210,000 04 Aug 2021 Common Stock 210,000 $8.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable as to one-third of the total shares on August 4, 2022 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months.